CHURCH: Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk

Sponsor
Columbia University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05174286
Collaborator
(none)
880
1
2
39
22.5

Study Details

Study Description

Brief Summary

The overarching goal of this proposal is to create a scalable community-academic partnership model for colorectal cancer (CRC) and cardiovascular disease (CVD) prevention for African American (AA) communities. Our dual intervention approach allows us to target two major killers of AAs, and aggressively pursue the mandate of this Program Announcement. We aim to (1) increase guideline concordant10 CRC screening uptake using a community health worker (CHW)-Led SBIRT intervention (Primary Outcome); and (2) reduce dietary and CVD risk factors linked to CRC (Secondary Outcomes). The latter will be addressed by culturally adapting an existing, evidence-based, web-based lifestyle program called Alive!, which has been shown in several RCTs to improve CVD outcomes. Using a Hybrid Type 1 Implementation-Effectiveness design, we will randomize 440 subjects from 22 AA churches into a cluster RCT to accomplish the following:

Specific Aim 1: To compare the effect of SBIRT (Intervention) to Referral As Usual (RAU) (Usual Care) on guideline-concordant CRC screening uptake. Hypothesis: Intervention will lead to increased CRC screening uptake (colonoscopy, fecal DNA) (Primary Outcome) compared to RAU at 6-months.

Aim 2: To evaluate the effect of a Culturally-adapted Alive! Program (CAP) incorporated into the intervention arm on dietary inflammatory score (DIS). Hypothesis: participants in the CAP arm will have lower DIS scores compared to RAU at 6-months.

Aim 3: To evaluate the effect of CAP on changes in Life Simple-7 (LS7) scores. Hypothesis:

participants in the CAP arm will have improvement in LS7 scores compared to RAU at 6-months and 1 year.

Aim 4: To examine the multi-level contextual mechanisms and factors influencing CHW effectiveness, reach, and implementation of CRC screening uptake and CAP activities. Guided by a racism-conscious adaptation of the Consolidated Framework for Implementation Research (CFIR) we will conduct a mixed methods process evaluation with key stakeholders to understand multi-level influences on CRC screening and CVD risk behaviors. This information will inform future dissemination and scale-up of this intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: SBIRT
  • Behavioral: Referral as Usual (RAU)
N/A

Detailed Description

Colorectal cancer (CRC) is the second most lethal cancer in the U.S with the highest incidence and mortality rates among African Americans (AAs) compared to other racial groups. Despite these disparities, which includes premature mortality, AAs are the least likely to undergo CRC screening, have precancerous colorectal polys removed, and have CRC detected at stages early enough for curative excision. Lower screening rates are linked to the downstream effects of structural inequities such as access to care, knowledge of screening options and benefits, health system mistrust, fear and anxiety. Although reducing the burden of CRC is best accomplished by screening, compelling evidence links inflammatory diets and cardiovascular disease (CVD) risk factors to increased CRC risk. In response to RFA-MD-21-007 to address two or more chronic diseases that commonly co-occur, share social contexts or risk factors, this proposal aims to develop a community-based prevention model to reduce CRC and CVD risk among AAs.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
880 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
Anticipated Study Start Date :
Jun 15, 2022
Anticipated Primary Completion Date :
Sep 15, 2025
Anticipated Study Completion Date :
Sep 15, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Screening, Brief Intervention, and Referral to Treatment (SBIRT)

1a) SBIRT is an evidence-based approach originally designed for people at risk of developing mental disorders. SBIRT is composed of three components: Screening with a validated instrument, Brief Intervention, Referral to Treatment. Motivational Interviewing (MI) is an empirically tested, person-centered, behavior change intervention designed to guide, elicit, and strengthen motivation for change. It decreases ambivalence and increases motivation for treatment. 1b) We will utilize the Culturally-adapted Alive! Program - a cost-effective, lifestyle coaching web-based automated platform that includes step-by-step individualized tailoring, feedback, and weekly guidance through interactive emails focused on increasing physical activity, improving eating habits, and weight control.

Behavioral: SBIRT
1a) SBIRT is an evidence-based approach originally designed for people at risk of developing mental disorders. SBIRT is composed of three components: Screening with a validated instrument, Brief Intervention, Referral to Treatment. Motivational Interviewing (MI) is an empirically tested, person-centered, behavior change intervention designed to guide, elicit, and strengthen motivation for change. It decreases ambivalence and increases motivation for treatment. 1b) We will utilize the Culturally-adapted Alive! Program - a cost-effective, lifestyle coaching web-based automated platform that includes step-by-step individualized tailoring, feedback, and weekly guidance through interactive emails focused on increasing physical activity, improving eating habits, and weight control
Other Names:
  • Culturally-adapted ALIVE! Program (CAP)
  • Active Comparator: Referral as Usual (RAU)

    Referral as Usual will involve distributing CRC health educational materials (e.g. NCI or CDC brochures that include new guidelines) and contact information for screening service providers in our target community.

    Behavioral: Referral as Usual (RAU)
    Referral as Usual will involve distributing CRC health educational materials (e.g. NCI or CDC brochures that include new guidelines) and contact information for screening service providers in our target community.

    Outcome Measures

    Primary Outcome Measures

    1. CRC Screening Uptake [Measured at 6 months post-screening]

      CRC screening uptake (colonoscopy, stool-based test) (Primary Outcome). This cluster RCT will evaluate the impact of a CHW enhanced CRC screening intervention on screening uptake (clinic-based colonoscopy or home-based stool test) (Primary Outcome). The definition of screening uptake is the subject's self-report of completing a CRC screening test plus the research team's verification of this completion from medical records. Screening uptake (clinic-based colonoscopy or home-based stool test) (Primary Outcome) is the subject's self-report of completing a CRC screening test plus the research team's verification of this completion from medical records.

    Secondary Outcome Measures

    1. Change in Dietary Inflammatory Score (Dietary Screening Measure) [Measured at baseline and 6 months post-screening]

      Assessment of participant eating habits via the culturally-adapted ALIVE! program will be captured by the Block Food Frequency Questionnaire (FFQ) that generates the dietary inflammatory score (DIS) which can be used to examine associations between inflammatory diets, cardiovascular diseases and colorectal cancer.

    2. Change in Life's Simple 7 Score (CVD Risk Screening Measure) [Measured at baseline, 6 months and 1 year post-screening]

      Evaluation of CVD risk factors using the Life Simple-7 (LS7) measure. LS7 scores range from 0 to 14 and are calculated from the composite of the factor scores. CVD health is then classified as inadequate (0-4), average (5-9), or optimum (10-14). Achieving a greater number of ideal LS7 metrics is associated with lower risk of dying after stroke and all cause cardiovascular mortality in a dose dependent manner.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. English-speaking

    2. Self-identifying as Black

    3. Aged 45 years and older

    4. Not up-to-date with CRC

    5. Working telephone

    6. Can provide informed consent

    Exclusion Criteria:
    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Columbia University Medical Center New York New York United States 10032

    Sponsors and Collaborators

    • Columbia University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Olajide Williams, Professor of Neurology, Columbia University
    ClinicalTrials.gov Identifier:
    NCT05174286
    Other Study ID Numbers:
    • AAAT9307
    First Posted:
    Dec 30, 2021
    Last Update Posted:
    Dec 30, 2021
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Olajide Williams, Professor of Neurology, Columbia University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 30, 2021